immunotherapy of cancer

About us

On March 14, 2023, Alligator published an interview with KOL on Mitazalimab and the Positive Interim Results from the OPTIMIZE-1 Phase 2 Trial in Pancreatic Cancer.

The discussion features Professor Jean-Luc Van Laethem, Principal Investigator of the OPTIMIZE-1 trial, and Dr. Sumeet Ambarkhane, Chief Medical Officer of Alligator Bioscience. They discuss perspectives on the current standard of care for patients with metastatic pancreatic cancer, what outcomes are associated with those therapies and the unmet medical needs. 

Click here for a link to the presentation.